FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for ondansetron hydrochloride from Aurobindo Pharma Limited, adding a new generic product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Nausea
• Postoperative Nausea and Vomiting
• Vomiting

Drugs mentioned

• Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON HYDROCHLORIDE (ONDANSETRON HYDROCHLORIDE)